Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 12, 2022

SELL
$41.2 - $73.6 $178,890 - $319,571
-4,342 Closed
0 $0
Q1 2021

Apr 14, 2021

SELL
$57.62 - $95.6 $27,427 - $45,505
-476 Reduced 9.88%
4,342 $296,000
Q4 2020

Jan 13, 2021

SELL
$41.43 - $77.09 $7,995 - $14,878
-193 Reduced 3.85%
4,818 $349,000
Q3 2020

Oct 08, 2020

BUY
$30.88 - $37.94 $154,739 - $190,117
5,011 New
5,011 $190,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Contravisory Investment Management, Inc. Portfolio

Follow Contravisory Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Contravisory Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Contravisory Investment Management, Inc. with notifications on news.